MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are the undisputed heavyweights in the prizefight for control of the rapidly growing weight-loss medications market. Beyond staggering sales figures for Novo’s Ozempic and Wegovy … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move that could have ramifications for a string of other pharmaceutical industry buyouts. Some Wall Street analysts … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday said it has reached a deal with drug giant Amgen to allow the company’s $27.8 billion purchase of Horizon … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo, boxes of the diabetes drug Ozempic sit on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images The European Union medicines regulator announced on Tuesday that it expanded the investigation in the risk of suicidal thoughts … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmaceutical CEOs testify before the Senate Finance Committee on “Drug Prices in America: A Prescription for Change, Part II” on February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, Chairman and CEO of AbbVie Inc; Pascal Soriot, CEO and Managing Director … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Robert Galbraith | Reuters Horizon Therapeutics expects its own Sales for $27.8 billion to Amgen to conclude as early as the end of the third quarter, earlier than planned – if the Federal Trade Commission try blocking business fails — after a document filed Thursday with … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo for Pfizer is displayed on a monitor on the floor of the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to finance your proposed acquisition manufacturer of anti-cancer drugs Seagenfor which … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Robert Galbraith | Reuters Horizon TherapeuticsThe stock price fell more than 17% in premarket trading on Tuesday following a report that Federal Trade Commission is preparing to file a lawsuit to block the biotech company Sales for $27.8 billion to Amgen. The FTC could sue to … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE (L-R) Richard A. Gonzalez, Chairman and CEO of AbbVie Inc., Pascal Soriot, CEO and CEO of AstraZeneca, Giovanni Caforio, Chairman and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist collects drugs for prescriptions at the pharmacy. Simon Dawson | Bloomberg | Getty Images Medicare is poised to renegotiate the prices of some of its most expensive drugs in a historic expansion of its power that could cut costs for many seniors as well … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Robert Califf testified during a hearing of the Senate Committee on Health, Education, Labor and Pensions on his nomination for Commissioner of the Food and Drug Administration on Tuesday, December 14, 2021. Bill Clark | CQ-Roll Call, Inc. | Getty Images On Tuesday, the Senate confirmed … Read more